Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TTGP7BY)

• DTT Name: Monoamine oxidase type B (MAO-B) DTT Info
• Gene Name: MAOB

Molecule-Related Drug & Molecule List

11 Approved Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Budipine	DMODHQI	Migraine	8A80	Approved	[1]
Indeloxazine	DMWO3N6	Dementia	6D80-6D86	Approved	[2]
Pargyline	DMM0HR1	Hypertension	BA00-BA04	Approved	[3]
Phenelzine	DMHIDUE	Depression	6A70-6A7Z	Approved	[4]
Rasagiline	DM3WKQ4	Parkinson disease	8A00.0	Approved	[5]
Safinamide	DM0YWJC	Parkinson disease	8A00.0	Approved	[6]
Safinamide mesylate	DM0J2ZT	Parkinson disease	8A00.0	Approved	[7]
Selegiline	DM6034S	Major depressive disorder	6A70.3	Approved	[8]
Selegiline Hydrochloride	DM3VR1L	Parkinson disease	8A00.0	Approved	[9]
Sulphadoxine	DMZI2UF	Malaria	1F40-1F45	Approved	[10]
Tranylcypromine	DMGB5RE	Major depressive disorder	6A70.3	Approved	[11]

11 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
P2B-001	DM9PVHX	Parkinson disease	8A00.0	Phase 3	[12]
Psoralen	DMIZJ8M	N. A.	N. A.	Phase 3	[13]
TRYPTAMINE	DMAFPHB	N. A.	N. A.	Phase 3	[14]
CHF-3381	DMQ2O8V	Neuropathic pain	8E43.0	Phase 2	[15]
EVT302	DM73XNG	Alzheimer disease	8A20	Phase 2	[16]
Ladostigil	DMJSY3Q	Alzheimer disease	8A20	Phase 2	[17]
ORY-2001	DMYM0UY	Alzheimer disease	8A20	Phase 2	[18]
RG1577	DMT1ZX0	Alzheimer disease	8A20	Phase 2	[19]
Neu-120	DMXKOUC	Parkinson disease	8A00.0	Phase 1/2	[20]
PIPERINE	DMYEAB1	Vitiligo	ED63.0	Phase 1/2	[21]
PF9601N	DMGLEM1	Parkinson disease	8A00.0	Phase 1	[22]

73 Patented Agent(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
3,4-Dihydroxybenzaldehyde	DM4O3DW	N. A.	N. A.	Patented	[23]
3-Hydroxy-2-butanone	DM9GPKR	N. A.	N. A.	Patented	[23]
4-Hydroxy-2,5-dimethyl-3(2H)-furanone	DM9L5KO	N. A.	N. A.	Patented	[23]
4-hydroxybenzaldehyde	DM471P5	Discovery agent	N.A.	Patented	[23]
4-Hydroxybenzoicacid	DM3WQNY	N. A.	N. A.	Patented	[23]
4-Hydroxybenzylalcohol	DMKDZMQ	N. A.	N. A.	Patented	[23]
4-Methoxybenzaldehyde	DMN6GTZ	N. A.	N. A.	Patented	[23]
Benzylcinnamate	DMD7Z3H	N. A.	N. A.	Patented	[23]
Coumaricacid	DM3ZGBH	N. A.	N. A.	Patented	[23]
Coumarin/resveratrol hybrid derivative 1	DMI1BKA	N. A.	N. A.	Patented	[24]
Coumarin/resveratrol hybrid derivative 2	DMK12OT	N. A.	N. A.	Patented	[24]
Cyclic peptide derivative 1	DM78NOU	N. A.	N. A.	Patented	[25]
Ethylvanillin	DM9WMJ1	N. A.	N. A.	Patented	[23]
EUGENOL	DM7US1H	Discovery agent	N.A.	Patented	[23]
FERULIC ACID	DMJC7NF	Discovery agent	N.A.	Patented	[23]
Heteroaryl-cyclopropylamine derivative 1	DMRF58Q	N. A.	N. A.	Patented	[25]
Heteroaryl-cyclopropylamine derivative 3	DMH9EQ1	N. A.	N. A.	Patented	[25]
Lazabemide	DMCULK7	Skin imperfections	EK71	Patented	[26]
Lazabemide analog 1	DM189D7	N. A.	N. A.	Patented	[24]
N-(2-phenylcyclopropyl) amino acid derivative 1	DMH7T8C	N. A.	N. A.	Patented	[25]
N-(2-phenylcyclopropyl) amino acid derivative 3	DMFBRSL	N. A.	N. A.	Patented	[25]
Piperonal	DME26SY	N. A.	N. A.	Patented	[23]
PMID25399762-Compound-Table 6-10	DM4UM03	N. A.	N. A.	Patented	[23]
PMID25399762-Compound-Table 6-11	DMYGTU2	N. A.	N. A.	Patented	[23]
PMID25399762-Compound-Table 6-12	DMZ07RP	N. A.	N. A.	Patented	[23]
PMID25399762-Compound-Table 6-13	DM6LR42	N. A.	N. A.	Patented	[23]
PMID25399762-Compound-Table 6-14	DMZHB9Y	N. A.	N. A.	Patented	[23]
PMID25399762-Compound-Table 6-15	DMCHWSF	N. A.	N. A.	Patented	[23]
PMID25399762-Compound-Table 6-9	DMDWIPG	N. A.	N. A.	Patented	[23]
PMID25399762-Compound-Table 7-Vanillic acid	DMSL3MB	N. A.	N. A.	Patented	[23]
PMID25399762-Compound-Table 7-Vanillyl alcohol	DM759MJ	N. A.	N. A.	Patented	[23]
PMID25399762-Compound-Table 7-Veratraldehyde	DM4J2SM	N. A.	N. A.	Patented	[23]
PMID25399762-Compound-Table1-C1	DMMP7HX	N. A.	N. A.	Patented	[23]
PMID25399762-Compound-Table1-C10	DMWY5XT	N. A.	N. A.	Patented	[23]
PMID25399762-Compound-Table1-C11	DMVASXW	N. A.	N. A.	Patented	[23]
PMID25399762-Compound-Table1-C12	DMF9X6P	N. A.	N. A.	Patented	[23]
PMID25399762-Compound-Table1-C13	DMD80Q6	N. A.	N. A.	Patented	[23]
PMID25399762-Compound-Table1-C14	DM7960M	N. A.	N. A.	Patented	[23]
PMID25399762-Compound-Table1-C15	DMR0P1U	N. A.	N. A.	Patented	[23]
PMID25399762-Compound-Table1-C16	DMYTEAC	N. A.	N. A.	Patented	[23]
PMID25399762-Compound-Table1-C17	DMNMU3R	N. A.	N. A.	Patented	[23]
PMID25399762-Compound-Table1-C18	DM2ZUVH	N. A.	N. A.	Patented	[23]
PMID25399762-Compound-Table1-C19	DMMO3F1	N. A.	N. A.	Patented	[23]
PMID25399762-Compound-Table1-C2	DMPFLGO	N. A.	N. A.	Patented	[23]
PMID25399762-Compound-Table1-C20	DMITNWZ	N. A.	N. A.	Patented	[23]
PMID25399762-Compound-Table1-C21	DMMFILA	N. A.	N. A.	Patented	[23]
PMID25399762-Compound-Table1-C22	DMBE0R2	N. A.	N. A.	Patented	[23]
PMID25399762-Compound-Table1-C23	DMF89PY	N. A.	N. A.	Patented	[23]
PMID25399762-Compound-Table1-C24	DMJK296	N. A.	N. A.	Patented	[23]
PMID25399762-Compound-Table1-C25	DMHT41B	N. A.	N. A.	Patented	[23]
PMID25399762-Compound-Table1-C3	DMXAKNH	N. A.	N. A.	Patented	[23]
PMID25399762-Compound-Table1-C4	DMJCVBM	N. A.	N. A.	Patented	[23]
PMID25399762-Compound-Table1-C5	DMEJNUG	N. A.	N. A.	Patented	[23]
PMID25399762-Compound-Table1-C6	DMY3UKC	N. A.	N. A.	Patented	[23]
PMID25399762-Compound-Table1-C7	DMQJV3L	N. A.	N. A.	Patented	[23]
PMID25399762-Compound-Table1-C8	DMRCPKV	N. A.	N. A.	Patented	[23]
PMID25399762-Compound-Table1-C9	DMVMT26	N. A.	N. A.	Patented	[23]
PMID29324067-Compound-38	DMPXZYN	N. A.	N. A.	Patented	[24]
PMID29324067-Compound-40	DM69A05	N. A.	N. A.	Patented	[24]
PMID29757691-Compound-4	DMFD9UZ	N. A.	N. A.	Patented	[27]
Schiff base compound 1	DMQD6IL	Alzheimer disease	8A20	Patented	[24]
Schiff base compound 2	DMWD20L	Alzheimer disease	8A20	Patented	[24]
Secondary and tertiary (hetero)arylamide derivative 1	DMEDNTJ	N. A.	N. A.	Patented	[24]
T83193	DMHO29Y	Discovery agent	N.A.	Patented	[23]
Tacrine-coumarin hybrid derivative 1	DM6YBTR	N. A.	N. A.	Patented	[24]
Tarnylcypromine derivative 2	DMEJR2F	N. A.	N. A.	Patented	[25]
Tarnylcypromine derivative 3	DMKJOMC	N. A.	N. A.	Patented	[25]
Tetra-hydro-isoquinoline derivative 1	DML86IO	N. A.	N. A.	Patented	[27]
Tetra-hydro-isoquinoline derivative 2	DM5CKVF	N. A.	N. A.	Patented	[27]
Tetra-hydro-isoquinoline derivative 3	DMCZA45	N. A.	N. A.	Patented	[27]
Tetra-hydro-isoquinoline derivative 4	DMDV0MP	N. A.	N. A.	Patented	[27]
Tetra-hydro-oxazolopyridine derivative 1	DM72MDA	N. A.	N. A.	Patented	[28]
Tetra-hydro-oxazolopyridine derivative 2	DMP65Z4	N. A.	N. A.	Patented	[28]

6 Discontinued Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
MOFEGILINE	DMJ59A4	Cognitive impairment	6D71	Discontinued in Phase 3	[29]
AS602868	DMKXDOI	Multiple myeloma	2A83	Discontinued in Phase 1	[13]
EVT-301	DMCZ8SF	Alzheimer disease	8A20	Discontinued in Phase 1	[30]
HT-1067	DMUPOIG	Parkinson disease	8A00.0	Discontinued in Phase 1	[31]
SL-25.1188	DMP0DLW	Alzheimer disease	8A20	Discontinued in Phase 1	[32]
Milacemide	DMJTR0U	Alzheimer disease	8A20	Terminated	[33]

1 Preclinical Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
RWJ-416457	DMH1FRY	Bacterial infection	1A00-1C4Z	Preclinical	[8]

237 Investigative Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
(+/-)-2-(4'-Benzyloxyphenyl)thiomorpholin-5-one	DMDXKQ6	Discovery agent	N.A.	Investigative	[34]
(+/-)-2-(4'-Benzyloxyphenyl)thiomorpholine	DMCB74T	Discovery agent	N.A.	Investigative	[34]
(+/-)-2-(4'-Butoxyphenyl)thiomorpholin-5-one	DM1WCJV	Discovery agent	N.A.	Investigative	[34]
(+/-)-2-(4'-Butoxyphenyl)thiomorpholine	DMG3MF2	Discovery agent	N.A.	Investigative	[34]
(+/-)-2-(4'-Ethoxyphenyl)thiomorpholin-5-one	DM1YBJ2	Discovery agent	N.A.	Investigative	[34]
(+/-)-2-(4'-Ethoxyphenyl)thiomorpholine	DMKPX7W	Discovery agent	N.A.	Investigative	[34]
(+/-)-2-(4'-Methoxyphenyl)thiomorpholin-5-one	DM7BY4T	Discovery agent	N.A.	Investigative	[34]
(+/-)-2-(4'-Methoxyphenyl)thiomorpholine	DMKFSQ8	Discovery agent	N.A.	Investigative	[34]
(+/-)-2-(4'-Propoxyphenyl)thiomorpholin-5-one	DMY1W20	Discovery agent	N.A.	Investigative	[34]
(+/-)-2-(4'-Propoxyphenyl)thiomorpholine	DMUPYN1	Discovery agent	N.A.	Investigative	[34]
(+/-)-2-(4-fluorophenyl)-7-methoxychroman-4-one	DMGY5WB	Discovery agent	N.A.	Investigative	[35]
(+/-)-2-(4-fluorophenyl)-7-methylchroman-4-one	DMHL7BC	Discovery agent	N.A.	Investigative	[35]
(+/-)-2-(4-fluorophenyl)chroman-4-one	DMXK4HR	Discovery agent	N.A.	Investigative	[35]
(+/-)-2-(4-methoxyphenyl)-7-methylchroman-4-one	DMTUFOE	Discovery agent	N.A.	Investigative	[35]
(+/-)-2-p-tolylchroman-4-one	DMYJGZ4	Discovery agent	N.A.	Investigative	[35]
(+/-)-2-Phenylthiomorpholin-5-one	DMSHDNO	Discovery agent	N.A.	Investigative	[34]
(+/-)-2-Phenylthiomorpholine	DMNR3YL	Discovery agent	N.A.	Investigative	[34]
(+/-)-7-fluoro-2-(4-fluorophenyl)chroman-4-one	DMKWBY8	Discovery agent	N.A.	Investigative	[35]
(+/-)-7-fluoro-2-(4-methoxyphenyl)chroman-4-one	DMYHV9P	Discovery agent	N.A.	Investigative	[35]
(+/-)-7-fluoro-2-p-tolylchroman-4-one	DM4H1JO	Discovery agent	N.A.	Investigative	[35]
(+/-)-7-fluoro-2-phenylchroman-4-one	DMJEBXA	Discovery agent	N.A.	Investigative	[35]
(+/-)-7-methoxy-2-(4-methoxyphenyl)chroman-4-one	DMYJGDK	Discovery agent	N.A.	Investigative	[35]
(+/-)-7-methoxy-2-p-tolylchroman-4-one	DMJMTVQ	Discovery agent	N.A.	Investigative	[35]
(+/-)-7-methoxy-2-phenylchroman-4-one	DMC0OKA	Discovery agent	N.A.	Investigative	[35]
(+/-)-7-methyl-2-p-tolylchroman-4-one	DMBN3WE	Discovery agent	N.A.	Investigative	[35]
(+/-)-7-methyl-2-phenylchroman-4-one	DMI3URD	Discovery agent	N.A.	Investigative	[35]
(6-Benzyloxy-2-naphthyl)-2-aminopropane	DMF7LST	Discovery agent	N.A.	Investigative	[36]
(6-Ethoxy-2-naphthyl)-2-aminopropane	DMM2EX6	Discovery agent	N.A.	Investigative	[36]
(6-Methoxy-2-naphthyl)-2-aminopropane	DM6YGQ3	Discovery agent	N.A.	Investigative	[36]
(6-Propoxy-2-naphthyl)-2-aminopropane	DMIFL3V	Discovery agent	N.A.	Investigative	[36]
(7-Benzyloxy-2-oxo-2H-chromen-4-yl)acetonitrile	DMB9YAO	Discovery agent	N.A.	Investigative	[37]
(E)-5-(3-Chlorostyryl)isatin	DMLIQUA	Discovery agent	N.A.	Investigative	[38]
(E)-5-(3-Fluorostyryl)isatin	DMP4T9Z	Discovery agent	N.A.	Investigative	[38]
(E)-5-Styrylisatin	DM1PCIX	Discovery agent	N.A.	Investigative	[38]
(E)-6-Styrylisatin	DMG47QU	Discovery agent	N.A.	Investigative	[38]
(E)-8-(3-chlorostyryl)-caffeine	DMQT15Z	Discovery agent	N.A.	Investigative	[39]
(R)(+)-2-(4-fluorophenyl)-7-methoxychroman-4-one	DM5UOFY	Discovery agent	N.A.	Investigative	[35]
(R)(+)-7-fluoro-2-(4-fluorophenyl)chroman-4-one	DM6WTLZ	Discovery agent	N.A.	Investigative	[35]
(R)(+)-7-fluoro-2-p-tolylchroman-4-one	DMHNKWR	Discovery agent	N.A.	Investigative	[35]
(R)(+)-7-fluoro-2-phenylchroman-4-one	DMJCN0Y	Discovery agent	N.A.	Investigative	[35]
(R)(+)-7-methyl-2-p-tolylchroman-4-one	DMVN50D	Discovery agent	N.A.	Investigative	[35]
(R)(+)-7-methyl-2-phenylchroman-4-one	DM8ZHYR	Discovery agent	N.A.	Investigative	[35]
(R)-3-Prop-2-ynylamino-indan-5-ol	DMPEV2W	Discovery agent	N.A.	Investigative	[40]
(R)-Indan-1-yl-methyl-prop-2-ynyl-amine	DMKFPMC	Discovery agent	N.A.	Investigative	[41]
(R)-N2-{4-[(3-chlorobenzyl)oxy]benzyl}alaninamide	DMPKWIN	Discovery agent	N.A.	Investigative	[42]
(R)-N2-{4-[(3-chlorobenzyl)oxy]benzyl}serinamide	DMEVM6G	Discovery agent	N.A.	Investigative	[42]
(R)-N2-{4-[(3-fluorobenzyl)oxy]benzyl}alaninamide	DMU49JN	Discovery agent	N.A.	Investigative	[42]
(R/R)BEFLOXATONE	DM8I6MG	Discovery agent	N.A.	Investigative	[43]
(S)(+)-2-(4-fluorophenyl)-7-methoxychroman-4-one	DMC5Z2I	Discovery agent	N.A.	Investigative	[35]
(S)(+)-7-fluoro-2-(4-fluorophenyl)chroman-4-one	DMILWE7	Discovery agent	N.A.	Investigative	[35]
(S)(+)-7-fluoro-2-p-tolylchroman-4-one	DMTFZBQ	Discovery agent	N.A.	Investigative	[35]
(S)(+)-7-fluoro-2-phenylchroman-4-one	DMHR1IB	Discovery agent	N.A.	Investigative	[35]
(S)(+)-7-methyl-2-p-tolylchroman-4-one	DMVBD6H	Discovery agent	N.A.	Investigative	[35]
(S)(+)-7-methyl-2-phenylchroman-4-one	DMBG4KN	Discovery agent	N.A.	Investigative	[35]
(S)-2-amino-1-(4-butylthiophenyl)-propane	DMPQ53V	Discovery agent	N.A.	Investigative	[44]
(S)-2-amino-1-(4-propylthiophenyl)-propane	DMAN7YJ	Discovery agent	N.A.	Investigative	[44]
(S)-N2-[4-(benzyloxy)benzyl]alaninamide	DMGMAPB	Discovery agent	N.A.	Investigative	[42]
(S)-N2-[4-(benzyloxy)benzyl]serinamide	DMW5ZK7	Discovery agent	N.A.	Investigative	[42]
(S)-N2-{4-[(3-chlorobenzyl)oxy]benzyl}alaninamide	DMKMJBL	Discovery agent	N.A.	Investigative	[42]
(S)-N2-{4-[(3-chlorobenzyl)oxy]benzyl}serinamide	DMINLCJ	Discovery agent	N.A.	Investigative	[42]
(S)-N2-{4-[(3-fluorobenzyl)oxy]benzyl}serinamide	DMSC8ZW	Discovery agent	N.A.	Investigative	[42]
(S)-N2-{4-[(4-chlorobenzyl)oxy]benzyl}alaninamide	DMU3F7H	Discovery agent	N.A.	Investigative	[42]
(S)-N2-{4-[(4-chlorobenzyl)oxy]benzyl}serinamide	DMLFOPV	Discovery agent	N.A.	Investigative	[42]
(S)-N2-{4-[(4-nitrobenzyl)oxy]benzyl}serinamide	DMLP63J	Discovery agent	N.A.	Investigative	[42]
1,2,3,4-Tetrahydro-naphthalen-1-ylamine	DMNXQ7Z	Discovery agent	N.A.	Investigative	[45]
1,2,3,4-Tetrahydro-pyrazino[1,2-a]indole	DM3JGVF	Discovery agent	N.A.	Investigative	[46]
1,4-diphenyl-(1E,3E)-1,3-butadiene	DMFY3VS	Discovery agent	N.A.	Investigative	[41]
1-(4-(benzyloxy)phenyl)propan-2-amine	DMT81N3	Discovery agent	N.A.	Investigative	[36]
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	DMPWB8G	Discovery agent	N.A.	Investigative	[47]
1H-Indole-2,3-dione	DMOZ91H	Discovery agent	N.A.	Investigative	[48]
2,3,4,5-Tetrahydro-1H-pyrido[4,3-b]indole	DMX8NYD	Discovery agent	N.A.	Investigative	[14]
2-(2,4-dichlorophenyl)-4,5-dihydro-1H-imidazole	DMDUF21	Discovery agent	N.A.	Investigative	[49]
2-(2-cycloheptylidenehydrazinyl)-4-phenylthiazole	DM187UQ	Discovery agent	N.A.	Investigative	[50]
2-(2-cyclohexylidenehydrazinyl)-4-p-tolylthiazole	DMTFWAQ	Discovery agent	N.A.	Investigative	[50]
2-(2-cyclohexylidenehydrazinyl)-4-phenylthiazole	DMPNGXE	Discovery agent	N.A.	Investigative	[50]
2-(2-cyclopentylidenehydrazinyl)-4-phenylthiazole	DMH1VCE	Discovery agent	N.A.	Investigative	[50]
2-(3-nitrophenyl)-4,5-dihydro-1H-imidazole	DMMYQ9R	Discovery agent	N.A.	Investigative	[49]
2-(4,5-dihydro-1H-imidazol-2-yl)quinoline	DM4X0SJ	Discovery agent	N.A.	Investigative	[49]
2-(4-chlorophenyl)-4,5-dihydro-1H-imidazole	DMFQI4C	Discovery agent	N.A.	Investigative	[49]
2-(4-fluorophenyl)-7-methoxy-4H-chromen-4-one	DMZDGB3	Discovery agent	N.A.	Investigative	[35]
2-(4-methoxyphenyl)-4H-chromene-4-thione	DMIDXTR	Discovery agent	N.A.	Investigative	[35]
2-(5-phenyl-furan-2-yl)-4,5-dihydro-1H-imidazole	DMDZ9RK	Discovery agent	N.A.	Investigative	[51]
2-(naphthalen-2-yl)-4,5-dihydro-1H-imidazole	DMKY71Z	Discovery agent	N.A.	Investigative	[49]
2-BFi	DMFAW4R	Discovery agent	N.A.	Investigative	[49]
2-Bromo-N-(2-morpholinoethyl)nicotinamide	DMYCENM	Discovery agent	N.A.	Investigative	[52]
2-Bromo-N-(3-morpholinopropyl)nicotinamide	DM9NMIO	Discovery agent	N.A.	Investigative	[52]
2-Chloro-N-(2-morpholinoethyl)nicotinamide	DMR8M36	Discovery agent	N.A.	Investigative	[52]
2-Chloro-N-(3-morpholinopropyl)nicotinamide	DM5S1DW	Discovery agent	N.A.	Investigative	[52]
2-Furan-2-yl-4,5-dihydro-1H-imidazole	DMQIFJ9	Discovery agent	N.A.	Investigative	[53]
2-Hydrazino-3-methyl-4(3H)-quinazolinone	DMOT1LQ	Discovery agent	N.A.	Investigative	[54]
2-methyl-9H-indeno[2,1-d]pyrimidin-9-one	DMEVFJW	Discovery agent	N.A.	Investigative	[55]
2-oxo-N-m-tolyl-2H-chromene-3-carboxamide	DMDKSZ0	Discovery agent	N.A.	Investigative	[56]
2-oxo-N-p-tolyl-2H-chromene-3-carboxamide	DMWXI6C	Discovery agent	N.A.	Investigative	[56]
2-oxo-N-phenyl-2H-chromene-3-carboxamide	DMH8QWY	Discovery agent	N.A.	Investigative	[56]
2-p-tolyl-4,5-dihydro-1H-imidazole	DM37S5C	Discovery agent	N.A.	Investigative	[49]
2-p-tolyl-4H-chromen-4-one	DMFWA9Y	Discovery agent	N.A.	Investigative	[35]
2-p-tolyl-4H-chromene-4-thione	DM2HKCM	Discovery agent	N.A.	Investigative	[35]
2-Phenethyl-4,5-dihydro-1H-imidazole	DM4H6PC	Discovery agent	N.A.	Investigative	[53]
2-Phenoxymethyl-4,5-dihydro-1H-imidazole	DM5E74G	Discovery agent	N.A.	Investigative	[53]
2-phenyl-9H-indeno[2,1-d]pyrimidine	DMMHSYV	Discovery agent	N.A.	Investigative	[55]
2-Phenyl-cyclopropylamine hydrochloride	DMUGH6J	Discovery agent	N.A.	Investigative	[57]
2-[7-(Benzyloxy)-2-oxo-2H-chromen-4-yl]acetamide	DMZFKDW	Discovery agent	N.A.	Investigative	[37]
3,4-Benzo-7-(beta-bromoallyloxy)-8-methylcoumarin	DMN4Z27	Discovery agent	N.A.	Investigative	[58]
3,4-Benzo-7-acetonyloxy-8-methoxycoumarin	DM1MC06	Discovery agent	N.A.	Investigative	[58]
3,4-Dichloro-N-(2-methyl-1H-indol-5-yl)benzamide	DMMZURL	Discovery agent	N.A.	Investigative	[59]
3-(2-Bromophenyl)-6-methylcoumarin	DMDM0R6	Discovery agent	N.A.	Investigative	[60]
3-(3-methoxyphenyl)-6-methyl-2H-chromen-2-one	DMZQ2CJ	Discovery agent	N.A.	Investigative	[61]
3-(4-hydroxyphenyl)-6-methyl-2H-chromen-2-one	DM3XOVL	Discovery agent	N.A.	Investigative	[61]
3-(4-methoxyphenyl)-6-methyl-2H-chromen-2-one	DMXKJOC	Discovery agent	N.A.	Investigative	[61]
3-(phenoxymethyl)-5H-indeno[1,2-c]pyridazin-5-one	DM2UPQG	Discovery agent	N.A.	Investigative	[55]
3-Chloro-N-(2-methyl-1H-indol-5-yl)benzamide	DMIEZGD	Discovery agent	N.A.	Investigative	[59]
3-phenyl-9H-indeno[1,2-e][1,2,4]triazin-9-one	DM830FW	Discovery agent	N.A.	Investigative	[55]
4,8-Dimethyl-7-(2'-oxocyclohexyloxy)coumarin	DMQNXL1	Discovery agent	N.A.	Investigative	[58]
4,9-Dihydro-3H-beta-carboline	DM27HMT	Discovery agent	N.A.	Investigative	[46]
4-(2-oxo-2H-chromene-3-carboxamido)benzoic acid	DMWIALU	Discovery agent	N.A.	Investigative	[56]
4-(Aminomethyl)-7-(benzyloxy)-2H-chromen-2-one	DMTB80W	Discovery agent	N.A.	Investigative	[37]
4-fluoroselegiline	DMRC49E	Dementia	6D80-6D86	Investigative	[62]
4-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN	DMNMJDL	Discovery agent	N.A.	Investigative	[40]
4-methyl-7-(2-oxocyclopentyloxy)-2H-chromen-2-one	DM9K7CQ	Discovery agent	N.A.	Investigative	[58]
4-oxo-4H-chromene-3-carboxylic acid	DM7GW4P	Discovery agent	N.A.	Investigative	[63]
4-phenyl-1,2,3,6-tetrahydropyridine	DMV6WC4	Discovery agent	N.A.	Investigative	[47]
5-Aminomethyl-3-pyrrol-1-yl-oxazolidin-2-one	DMWDUVC	Discovery agent	N.A.	Investigative	[43]
5-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline	DMMI4H3	Discovery agent	N.A.	Investigative	[14]
5-Bromo-4,9-dihydro-3H-beta-carboline	DM2SEFR	Discovery agent	N.A.	Investigative	[14]
5-Hydroxymethyl-3-pyrrol-1-yl-oxazolidin-2-one	DMT9FQN	Discovery agent	N.A.	Investigative	[43]
5-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline	DMNRSYA	Discovery agent	N.A.	Investigative	[14]
5-Methoxy-4,9-dihydro-3H-beta-carboline	DMBOMZE	Discovery agent	N.A.	Investigative	[14]
5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE	DMVX063	Discovery agent	N.A.	Investigative	[64]
6-amino-9-methoxy-7H-furo[3,2-g]chromen-7-one	DMU1CV4	Discovery agent	N.A.	Investigative	[58]
6-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline	DMXQ8K1	Discovery agent	N.A.	Investigative	[14]
6-Bromo-4,9-dihydro-3H-beta-carboline	DM64KOZ	Discovery agent	N.A.	Investigative	[14]
6-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline	DMSA367	Discovery agent	N.A.	Investigative	[46]
6-Methoxy-4,9-dihydro-3H-beta-carboline	DM98FQO	Discovery agent	N.A.	Investigative	[46]
7-(3-chlorobenzyloxy)-4-carboxaldehyde-coumarin	DM762G3	Discovery agent	N.A.	Investigative	[65]
7-Acetonyloxy-3,4-cyclohexene-8-methylcoumarin	DMQCDT1	Discovery agent	N.A.	Investigative	[58]
7-Acetonyloxy-3,4-cyclopentene-8-methylcoumarin	DMQMTSX	Discovery agent	N.A.	Investigative	[58]
7-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline	DMVTH0Q	Discovery agent	N.A.	Investigative	[14]
7-Bromo-4,9-dihydro-3H-beta-carboline	DMCWYT7	Discovery agent	N.A.	Investigative	[14]
7-fluoro-2-(4-fluorophenyl)-4H-chromene-4-thione	DM4HJZI	Discovery agent	N.A.	Investigative	[35]
7-fluoro-2-(4-methoxyphenyl)-4H-chromen-4-one	DMUPXBJ	Discovery agent	N.A.	Investigative	[35]
7-fluoro-2-p-tolyl-4H-chromen-4-one	DMFOU8G	Discovery agent	N.A.	Investigative	[35]
7-fluoro-2-p-tolyl-4H-chromene-4-thione	DMJFXKA	Discovery agent	N.A.	Investigative	[35]
7-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline	DMQ1BE8	Discovery agent	N.A.	Investigative	[53]
7-methoxy-2-p-tolyl-4H-chromen-4-one	DME5WZQ	Discovery agent	N.A.	Investigative	[35]
7-methoxy-2-p-tolyl-4H-chromene-4-thione	DM4WMGK	Discovery agent	N.A.	Investigative	[35]
7-Methoxy-9H-beta-carboline	DMHKMU1	Discovery agent	N.A.	Investigative	[14]
7-methyl-2-p-tolyl-4H-chromene-4-thione	DMB9YA8	Discovery agent	N.A.	Investigative	[35]
8-(3-Bromobenzyloxy)caffeine	DM2RA4N	Discovery agent	N.A.	Investigative	[66]
8-(3-Chlorobenzyloxy)caffeine	DM7HMNP	Discovery agent	N.A.	Investigative	[66]
8-(3-Fluorobenzyloxy)caffeine	DME85GS	Discovery agent	N.A.	Investigative	[66]
8-(3-Methoxybenzyloxy)caffeine	DMLY46X	Discovery agent	N.A.	Investigative	[66]
8-(3-Methylbenzyloxy)caffeine	DMB9645	Discovery agent	N.A.	Investigative	[66]
8-Benzyloxycaffeine	DMJQ8AP	Discovery agent	N.A.	Investigative	[66]
8-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline	DMALRU4	Discovery agent	N.A.	Investigative	[14]
8-Bromo-4,9-dihydro-3H-beta-carboline	DM4V5RU	Discovery agent	N.A.	Investigative	[14]
8-Bromo-6-methyl-3-(4'-methoxyphenyl)coumarin	DM51FL9	Discovery agent	N.A.	Investigative	[60]
8-Bromo-6-methyl-3-phenylcoumarin	DMD1LM8	Discovery agent	N.A.	Investigative	[60]
8-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline	DMHE7J5	Discovery agent	N.A.	Investigative	[14]
8-Methoxy-4,9-dihydro-3H-beta-carboline	DM8MBSN	Discovery agent	N.A.	Investigative	[14]
8-[(3-Trifluoromethyl)benzyloxy]caffeine	DMT3IOB	Discovery agent	N.A.	Investigative	[66]
9-Methyl-2,3,4,9-tetrahydro-1H-beta-carboline	DMF7QS5	Discovery agent	N.A.	Investigative	[14]
Benzyl-methyl-[1-(1H-pyrrol-2-yl)-vinyl]-amine	DMQAEOL	Discovery agent	N.A.	Investigative	[67]
Beta-methoxyamphetamine	DMA9CSG	Discovery agent	N.A.	Investigative	[68]
Butyl-methyl-prop-2-ynyl-amine hydrochloride	DMJUTWG	Discovery agent	N.A.	Investigative	[69]
C-(1H-Indol-3-yl)-methylamine	DMDLK9G	Discovery agent	N.A.	Investigative	[14]
CGS-19281A	DMDB2KJ	Discovery agent	N.A.	Investigative	[46]
CHALCONE	DM16QTM	Discovery agent	N.A.	Investigative	[70]
Cis-2-(4-chlorophenyl)-2-fluorocyclopropanamine	DMVRF9H	Discovery agent	N.A.	Investigative	[71]
Cis-2-(para-fluorophenyl)cyclopropylamine	DMPZ1LY	Discovery agent	N.A.	Investigative	[71]
Cis-2-Fluoro-2-(4-methoxyphenyl)cyclopropylamine	DMNG9B2	Discovery agent	N.A.	Investigative	[71]
Cis-2-fluoro-2-phenylcyclopropanamine	DMFSPHE	Discovery agent	N.A.	Investigative	[71]
Cis-2-phenylcyclopropylamine	DMKZ32J	Discovery agent	N.A.	Investigative	[71]
CORDOIN	DMT5SED	Discovery agent	N.A.	Investigative	[70]
Deprenyl	DMRFBD0	Discovery agent	N.A.	Investigative	[72]
Farnesol	DMV2X1B	Discovery agent	N.A.	Investigative	[40]
Flavanone	DMNWIYM	Discovery agent	N.A.	Investigative	[35]
Flavin-Adenine Dinucleotide	DM5S4GK	Discovery agent	N.A.	Investigative	[73]
Heptyl-methyl-prop-2-ynyl-amine hydrochloride	DM1NUO5	Discovery agent	N.A.	Investigative	[69]
HYDRAZINECARBOXAMIDE	DMARWG5	Discovery agent	N.A.	Investigative	[57]
IPRONIAZIDE	DM42ENF	Discovery agent	N.A.	Investigative	[52]
Isopropyl-methyl-prop-2-ynyl-amine hydrochloride	DM92F6Z	Discovery agent	N.A.	Investigative	[69]
JD-0100	DMLBX3Q	Obesity	5B81	Investigative	[8]
L-136662	DMWNJV0	Discovery agent	N.A.	Investigative	[64]
Lauryl Dimethylamine-N-Oxide	DM3W2OE	Discovery agent	N.A.	Investigative	[73]
LU-53439	DMGYBSC	Discovery agent	N.A.	Investigative	[74]
Methyl piperate	DMW2R3M	Discovery agent	N.A.	Investigative	[21]
Methyl-(1,2,3,4-tetrahydro-naphthalen-1-yl)-amine	DM9Y4FL	Discovery agent	N.A.	Investigative	[45]
Methyl-pentyl-prop-2-ynyl-amine oxalic acid	DMQ7THK	Discovery agent	N.A.	Investigative	[69]
MMDA	DMUWVGP	Discovery agent	N.A.	Investigative	[73]
N-(1H-Indol-2-ylmethyl)-N-methyl-N-phenylamine	DMCM51R	Discovery agent	N.A.	Investigative	[75]
N-(1H-Indol-2-ylmethyl)-N-phenylamine	DMXD592	Discovery agent	N.A.	Investigative	[75]
N-(2-aminoethyl)-2-oxo-2H-chromene-3-carboxamide	DM7SUTQ	Discovery agent	N.A.	Investigative	[56]
N-(2-aminoethyl)-p-chlorobenzamide	DMLSFQI	Discovery agent	N.A.	Investigative	[40]
N-(2-Methyl-1H-indol-5-yl)benzamide	DMH42YF	Discovery agent	N.A.	Investigative	[59]
N-(2-Methyl-1H-indol-5-yl)cyclohexanecarboxamide	DM3SF5M	Discovery agent	N.A.	Investigative	[59]
N-(2-phenylethyl),N-(pyrrol-2-ylmethyl)amine	DM1ADE5	Discovery agent	N.A.	Investigative	[76]
N-(2-Phenylethyl)-1H-indole-2-carboxamide	DMJCO7F	Discovery agent	N.A.	Investigative	[75]
N-(3-Phenylpropyl)-1H-indole-2-carboxamide	DMKAX3Q	Discovery agent	N.A.	Investigative	[75]
N-(4-Ethylphenyl)-2-oxo-2H-chromene-3-carboxamide	DMWTVJH	Discovery agent	N.A.	Investigative	[56]
N-(4-Phenylbutyl)-1H-indole-2-carboxamide	DMTCMUG	Discovery agent	N.A.	Investigative	[75]
N-(benzyl),N-(pyrrol-2-ylmethyl)amine	DM87YJW	Discovery agent	N.A.	Investigative	[76]
N-(propargyl),N-(pyrrol-2-ylmethyl)amine	DMTJ5WL	Discovery agent	N.A.	Investigative	[76]
N-Benzyl,N-methyl-1H-indole-2-carboxamide	DMHVRFM	Discovery agent	N.A.	Investigative	[75]
N-Benzyl-1H-indole-2-carboxamide	DMA3YWU	Discovery agent	N.A.	Investigative	[75]
N-benzyl-2-oxo-2H-chromene-3-carboxamide	DMJ29MN	Discovery agent	N.A.	Investigative	[56]
N-Benzyl-N-(1H-indol-2-ylmethyl)-N-methylamine	DM0NJAL	Discovery agent	N.A.	Investigative	[75]
N-cyclohexyl-2-oxo-2H-chromene-3-carboxamide	DMRA548	Discovery agent	N.A.	Investigative	[56]
N-isobutyl-2-oxo-2H-chromene-3-carboxamide	DMO4E9U	Discovery agent	N.A.	Investigative	[56]
N-methyl,N-(benzyl),N-(pyrrol-2-ylmethyl)amine	DM83AEM	Discovery agent	N.A.	Investigative	[76]
N-methyl,N-(propargyl),N-(pyrrol-2-ylmethyl)amine	DMZ24XT	Discovery agent	N.A.	Investigative	[76]
N-Methyl,N-phenyl-1H-indole-2-carboxamide	DMM3B21	Discovery agent	N.A.	Investigative	[75]
N-Methyl-N-phenyl-2-oxo-2H-chromene-3-carboxamide	DMDB7ZM	Discovery agent	N.A.	Investigative	[56]
N-Methyl-N-Propargyl-1(R)-Aminoindan	DMB9OGI	Discovery agent	N.A.	Investigative	[40]
N-Phenyl-1H-indole-2-carboxamide	DM7V025	Discovery agent	N.A.	Investigative	[75]
N-Propargyl-1(S)-Aminoindan	DMHZCLV	Discovery agent	N.A.	Investigative	[40]
N2-[4-(benzyloxy)benzyl]glycinamide	DMOZ1IY	Discovery agent	N.A.	Investigative	[42]
N2-{4-[(3-chlorobenzyl)oxy]benzyl}glycinamide	DMHJ2IP	Discovery agent	N.A.	Investigative	[42]
N2-{4-[(3-fluorobenzyl)oxy]benzyl}glycinamide	DMEWP9L	Discovery agent	N.A.	Investigative	[42]
N2-{4-[(4-chlorobenzyl)oxy]benzyl}glycinamide	DMLPJGX	Discovery agent	N.A.	Investigative	[42]
N2-{4-[(4-nitrobenzyl)oxy]benzyl}glycinamide	DMAVB0G	Discovery agent	N.A.	Investigative	[42]
NSC-50187	DMTQP3V	Discovery agent	N.A.	Investigative	[35]
NSC-93405	DM3BZ7S	Discovery agent	N.A.	Investigative	[35]
NW-1772	DMRYBK6	Neurodegenerative disorder	8A20-8A23	Investigative	[8]
Phenyl 4-(4,5-dihydro-1H-imidazol-2-yl)benzoate	DMHDWTS	Discovery agent	N.A.	Investigative	[49]
PNU-22394	DMHTPSF	Discovery agent	N.A.	Investigative	[14]
RS-1636	DMKQT1Y	Discovery agent	N.A.	Investigative	[10]
SKL-PD	DM4X2GH	Central nervous system disease	8A04-8D87	Investigative	[8]
TOLOXATONE	DMHV5NK	Discovery agent	N.A.	Investigative	[43]
TRACIZOLINE	DM18CV3	Discovery agent	N.A.	Investigative	[53]
Trans-2-(4-chlorophenyl)-2-fluorocyclopropanamine	DMH1S57	Discovery agent	N.A.	Investigative	[71]
Trans-2-fluoro-2-(4-fluorophenyl)cyclopropanamine	DMO01T8	Discovery agent	N.A.	Investigative	[71]
Trans-2-fluoro-2-p-tolylcyclopropanamine	DM392QT	Discovery agent	N.A.	Investigative	[71]
Trans-2-fluoro-2-phenylcyclopropylamin	DMVGAFR	Discovery agent	N.A.	Investigative	[71]
TRYPTOLINE	DMV19K7	Discovery agent	N.A.	Investigative	[53]
VAR-10200	DMD7M9L	Neurodegenerative disorder	8A20-8A23	Investigative	[8]
VAR-10300	DMFKTPO	Neurodegenerative disorder	8A20-8A23	Investigative	[8]
[(1e)-4-Phenylbut-1-Enyl]Benzene	DMG1ATX	Discovery agent	N.A.	Investigative	[40]

References

• [1] Multiple mechanisms of action: the pharmacological profile of budipine. J Neural Transm Suppl. 1999;56:83-105.
• [2] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
• [3] Dose-dependent activation of distinct hypertrophic pathways by serotonin in cardiac cells. Am J Physiol Heart Circ Physiol. 2009 Aug;297(2):H821-8.
• [4] Limitation of adipose tissue enlargement in rats chronically treated with semicarbazide-sensitive amine oxidase and monoamine oxidase inhibitors. Pharmacol Res. 2008 Jun;57(6):426-34.
• [5] Glyceraldehyde-3-phosphate dehydrogenase-monoamine oxidase B-mediated cell death-induced by ethanol is prevented by rasagiline and 1-R-aminoindan. Neurotox Res. 2009 Aug;16(2):148-59.
• [6] Emerging drugs for epilepsy. Expert Opin Emerg Drugs. 2007 Sep;12(3):407-22.
• [7] 2017 FDA drug approvals.Nat Rev Drug Discov. 2018 Feb;17(2):81-85.
• [8] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2490).
• [9] Emerging drugs for Parkinson's disease. Expert Opin Emerg Drugs. 2006 Sep;11(3):403-17.
• [10] Novel monoamine oxidase inhibitors, 3-(2-aminoethoxy)-1,2-benzisoxazole derivatives, and their differential reversibility. Jpn J Pharmacol. 2002 Feb;88(2):174-82.
• [11] Tranylcypromine: new perspectives on an "old" drug. Eur Arch Psychiatry Clin Neurosci. 2006 Aug;256(5):268-73.
• [12] Rasagiline (TVP-1012): a new selective monoamine oxidase inhibitor for Parkinson's disease. Am J Geriatr Pharmacother. 2006 Dec;4(4):330-46.
• [13] Inhibition of rat brain monoamine oxidase activities by psoralen and isopsoralen: implications for the treatment of affective disorders. Pharmacol Toxicol. 2001 Feb;88(2):75-80.
• [14] Binding of beta-carbolines at imidazoline I2 receptors: a structure-affinity investigation. Bioorg Med Chem Lett. 2004 Feb 23;14(4):999-1002.
• [15] Emerging drugs in neuropathic pain. Expert Opin Emerg Drugs. 2007 Mar;12(1):113-26.
• [16] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [17] Ladostigil: a novel multimodal neuroprotective drug with cholinesterase and brain-selective monoamine oxidase inhibitory activities for Alzheimer's disease treatment. Curr Drug Targets. 2012 Apr;13(4):483-94.
• [18] Clinical pipeline report, company report or official report of Oryzon Genomics Boston, MA
• [19] Sembragiline Alzheimer's Disease (Phase 2). Evotech AG, Roche.
• [20] Company report (Neurim Pharmaceuticals)
• [21] Proposed structural basis of interaction of piperine and related compounds with monoamine oxidases. Bioorg Med Chem Lett. 2010 Jan 15;20(2):537-40.
• [22] Drugs used to treat Parkinson's disease, present status and future directions. CNS Neurol Disord Drug Targets. 2008 Oct;7(4):321-42.
• [23] Novel monoamine oxidase inhibitors: a patent review (2012 - 2014).Expert Opin Ther Pat. 2015 Jan;25(1):91-110.
• [24] MAO inhibitors and their wider applications: a patent review.Expert Opin Ther Pat. 2018 Mar;28(3):211-226.
• [25] LSD1 inhibitors: a patent review (2010-2015).Expert Opin Ther Pat. 2016 May;26(5):565-80.
• [26] The activity of MAO A and B in rat renal cells and tubules. Life Sci. 1998;62(8):727-37.
• [27] A patent review of butyrylcholinesterase inhibitors and reactivators 2010-2017.Expert Opin Ther Pat. 2018 Jun;28(6):455-465.
• [28] mGlu5 negative allosteric modulators: a patent review (2013 - 2016).Expert Opin Ther Pat. 2017 Jun;27(6):691-706.
• [29] Structural and mechanistic studies of mofegiline inhibition of recombinant human monoamine oxidase B. J Med Chem. 2008 Dec 25;51(24):8019-26.
• [30] Assessment of MAO-B occupancy in the brain with PET and [11C]-L-deprenyl-D2: a dose-finding study with a novel MAO-B inhibitor, EVT 301. Clin Pharmacol Ther. 2009 May;85(5):506-12.
• [31] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800034020)
• [32] [(11)C]SL25.1188, a new reversible radioligand to study the monoamine oxidase type B with PET: preclinical characterisation in nonhuman primate. Synapse. 2010 Jan;64(1):61-9.
• [33] Milacemide, the selective substrate and enzyme-activated specific inhibitor of monoamine oxidase B, increases dopamine but not serotonin in caudate nucleus of rhesus monkey. Neurochem Int. 1990;17(2):325-9.
• [34] 2-Arylthiomorpholine derivatives as potent and selective monoamine oxidase B inhibitors. Bioorg Med Chem. 2010 Feb 15;18(4):1388-95.
• [35] A new series of flavones, thioflavones, and flavanones as selective monoamine oxidase-B inhibitors. Bioorg Med Chem. 2010 Feb;18(3):1273-9.
• [36] Naphthylisopropylamine and N-benzylamphetamine derivatives as monoamine oxidase inhibitors. Bioorg Med Chem. 2009 Mar 15;17(6):2452-60.
• [37] Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)ox... J Med Chem. 2009 Nov 12;52(21):6685-706.
• [38] Inhibition of monoamine oxidase by (E)-styrylisatin analogues. Bioorg Med Chem Lett. 2009 May 1;19(9):2509-13.
• [39] Synthesis and in vitro evaluation of pteridine analogues as monoamine oxidase B and nitric oxide synthase inhibitors. Bioorg Med Chem. 2009 Nov 1;17(21):7523-30.
• [40] The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
• [41] Docking studies on monoamine oxidase-B inhibitors: estimation of inhibition constants (K(i)) of a series of experimentally tested compounds. Bioorg Med Chem Lett. 2005 Oct 15;15(20):4438-46.
• [42] Solid-phase synthesis and insights into structure-activity relationships of safinamide analogues as potent and selective inhibitors of type B monoa... J Med Chem. 2007 Oct 4;50(20):4909-16.
• [43] 3-(1H-Pyrrol-1-yl)-2-oxazolidinones as reversible, highly potent, and selective inhibitors of monoamine oxidase type A. J Med Chem. 2002 Mar 14;45(6):1180-3.
• [44] Human and rat monoamine oxidase-A are differentially inhibited by (S)-4-alkylthioamphetamine derivatives: insights from molecular modeling studies. Bioorg Med Chem. 2007 Aug 1;15(15):5198-206.
• [45] Stereoisomers of allenic amines as inactivators of monoamine oxidase type B. Stereochemical probes of the active site. J Med Chem. 1988 Aug;31(8):1558-66.
• [46] Pyrazino[1,2-a]indoles as novel high-affinity and selective imidazoline I(2) receptor ligands. Bioorg Med Chem Lett. 2004 Feb 23;14(4):1003-5.
• [47] Further explorations of unnatural alkaloids. J Nat Prod. 1985 Nov-Dec;48(6):878-93.
• [48] DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-41.
• [49] Ultrasound promoted synthesis of 2-imidazolines in water: a greener approach toward monoamine oxidase inhibitors. Bioorg Med Chem Lett. 2009 Jan 15;19(2):546-9.
• [50] Synthesis, semipreparative HPLC separation, biological evaluation, and 3D-QSAR of hydrazothiazole derivatives as human monoamine oxidase B inhibitors. Bioorg Med Chem. 2010 Jul 15;18(14):5063-70.
• [51] 3-[5-(4,5-dihydro-1H-imidazol-2-yl)-furan-2-yl]phenylamine (Amifuraline), a promising reversible and selective peripheral MAO-A inhibitor. J Med Chem. 2006 Sep 7;49(18):5578-86.
• [52] Design of novel nicotinamides as potent and selective monoamine oxidase a inhibitors. Bioorg Med Chem. 2010 Feb 15;18(4):1659-64.
• [53] Binding of an imidazopyridoindole at imidazoline I2 receptors. Bioorg Med Chem Lett. 2004 Jan 19;14(2):527-9.
• [54] New pyrazoline bearing 4(3H)-quinazolinone inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A ... Bioorg Med Chem. 2009 Jan 15;17(2):675-89.
• [55] Synthesis and monoamine oxidase inhibitory activity of new pyridazine-, pyrimidine- and 1,2,4-triazine-containing tricyclic derivatives. J Med Chem. 2007 Nov 1;50(22):5364-71.
• [56] Synthesis, molecular modeling, and selective inhibitory activity against human monoamine oxidases of 3-carboxamido-7-substituted coumarins. J Med Chem. 2009 Apr 9;52(7):1935-42.
• [57] Fluorinated phenylcyclopropylamines. 2. Effects of aromatic ring substitution and of absolute configuration on inhibition of microbial tyramine oxi... J Med Chem. 2004 Nov 18;47(24):5860-71.
• [58] Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. J Med Chem. 2008 Nov 13;51(21):6740-51.
• [59] Inhibition of monoamine oxidase by indole and benzofuran derivatives. Eur J Med Chem. 2010 Oct;45(10):4458-66.
• [60] New halogenated 3-phenylcoumarins as potent and selective MAO-B inhibitors. Bioorg Med Chem Lett. 2010 Sep 1;20(17):5157-60.
• [61] Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors. Bioorg Med Chem Lett. 2009 Sep 1;19(17):5053-5.
• [62] Multiple, small dose administration of (-)deprenyl enhances catecholaminergic activity and diminishes serotoninergic activity in the brain and these effects are unrelated to MAO-B inhibition. Arch Int Pharmacodyn Ther. 1994 Jul-Aug;328(1):1-15.
• [63] Chromone-2- and -3-carboxylic acids inhibit differently monoamine oxidases A and B. Bioorg Med Chem Lett. 2010 May 1;20(9):2709-12.
• [64] Identification of novel monoamine oxidase B inhibitors by structure-based virtual screening. Bioorg Med Chem Lett. 2010 Sep 1;20(17):5295-8.
• [65] Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs. J Med Chem. 2007 Nov 15;50(23):5848-52.
• [66] Inhibition of monoamine oxidase by 8-benzyloxycaffeine analogues. Bioorg Med Chem. 2010 Feb;18(3):1018-28.
• [67] Simple, potent, and selective pyrrole inhibitors of monoamine oxidase types A and B. J Med Chem. 2003 Mar 13;46(6):917-20.
• [68] Differential behavioural and neurochemical effects of para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine in the rat. Prog Neuropsychopharmacol Biol Psychiatry. 2000 Aug;24(6):955-77.
• [69] Aliphatic propargylamines: potent, selective, irreversible monoamine oxidase B inhibitors. J Med Chem. 1992 Oct 2;35(20):3705-13.
• [70] Chalcones: a valid scaffold for monoamine oxidases inhibitors. J Med Chem. 2009 May 14;52(9):2818-24.
• [71] Fluorinated phenylcyclopropylamines. Part 5: Effects of electron-withdrawing or -donating aryl substituents on the inhibition of monoamine oxidases... Bioorg Med Chem. 2008 Aug 1;16(15):7148-66.
• [72] The effect of deprenyl washout in patients with long-standing Parkinson's disease. J Neural Transm. 2002 May;109(5-6):797-803.
• [73] How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
• [74] Inhibition of monoamine oxidase type A, but not type B, is an effective means of inducing anticonvulsant activity in the kindling model of epilepsy. J Pharmacol Exp Ther. 1999 Mar;288(3):984-92.
• [75] Synthesis, structure-activity relationships and molecular modeling studies of new indole inhibitors of monoamine oxidases A and B. Bioorg Med Chem. 2008 Nov 15;16(22):9729-40.
• [76] New pyrrole inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity. J Med Chem. 2007 Mar 8;50(5):922-31.